Our memory reflects our brain health and it is often lost in old age, majorly due to dementia.Dementia is basically caused by ...

Q3 2025 Earnings Call Transcript December 5, 2025 Operator: Welcome to the Beta Technologies Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Devon ...

For millennia, humans evolved beneath open skies, surrounded by forests, rivers and the rhythms of the natural world. This ...

UC Santa Cruz research innovations and academic programs advance brain and mental health.

The Lancia Pu+Ra HPE concept marks the Italian brand's electric rebirth, blending "Pure" and "Radical" design with Stratos-inspired geometry. Featuring a "home-like" interior by Cassina and the new ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aß). Lecanemab has been approved in 51 ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

Gold Spot US Dollar, Silver Spot US Dollar, S&P 500, Oracle Corporation. Read 's Market Analysis on Investing.com ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai presented the latest findings on time saved with continued treatment with lecanemab (Leqembi®) at the 18th Clinical Trials in Alzheimer's ...

AD is a progressive, relentless disease with Aβ and tau as hallmarks. It is caused by a continuous underlying neurotoxic process driven by PF that begins before amyloid plaque accumulation and ...